Volume 74, Issue 1, Pages (July 2008)

Slides:



Advertisements
Similar presentations
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Advertisements

Volume 66, Issue 6, Pages (December 2004)
Volume 64, Issue 3, Pages (September 2003)
Volume 58, Issue 1, Pages (July 2000)
Volume 70, Issue 1, Pages (July 2006)
Volume 68, Issue 2, Pages (August 2005)
Volume 56, Issue 3, Pages (September 1999)
Volume 78, Issue 2, Pages (July 2010)
Urea channel inhibitors: a new functional class of aquaretics
Volume 64, Issue 1, Pages (July 2003)
Volume 80, Issue 6, Pages (September 2011)
Volume 63, Issue 3, Pages (March 2003)
Volume 56, Issue 6, Pages (December 1999)
Volume 55, Issue 4, Pages (April 1999)
Volume 69, Issue 12, Pages (June 2006)
Volume 83, Issue 5, Pages (May 2013)
Volume 66, Issue 6, Pages (December 2004)
Volume 54, Issue 2, Pages (August 1998)
Volume 61, Issue 5, Pages (May 2002)
Localization of the prostacyclin receptor in human kidney
Interstitial tonicity controls TonEBP expression in the renal medulla
Volume 61, Issue 6, Pages (June 2002)
Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells  Hanne B. Moeller, Mark A. Knepper, Robert.
Volume 69, Issue 1, Pages (January 2006)
Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats  Andrew P. Evan, Sharon B. Bledsoe, Susan.
Volume 69, Issue 1, Pages (January 2006)
Volume 61, Issue 3, Pages (March 2002)
Differential expression of adenylyl cyclases in the rat nephron
Urea channel inhibitors: a new functional class of aquaretics
Volume 74, Issue 12, Pages (December 2008)
Volume 67, Issue 2, Pages (February 2005)
Volume 63, Issue 2, Pages (February 2003)
IL-18 is expressed in the intercalated cell of human kidney
Volume 60, Issue 5, Pages (November 2001)
Experimental ischemia–reperfusion: biases and myths—the proximal vs
Volume 57, Issue 5, Pages (May 2000)
Vasopressin in chronic kidney disease: an elephant in the room?
Cellular responses to hypoxia after renal segmental infarction
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Kenji Kasuno, Hajime Nakamura, Takahiko Ono, Eri Muso, Junji Yodoi 
Volume 63, Issue 4, Pages (April 2003)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Adaptation to hypoxia in the diabetic rat kidney
Autoantibodies against intercalated cells in Sjögren's syndrome
Volume 65, Issue 2, Pages (February 2004)
Volume 73, Issue 9, Pages (May 2008)
Volume 58, Issue 2, Pages (August 2000)
Volume 54, Pages S22-S28 (September 1998)
Volume 67, Issue 4, Pages (April 2005)
Calcitonin receptor isoforms expressed in the developing rat kidney
Volume 54, Issue 4, Pages (October 1998)
Volume 59, Issue 1, Pages (January 2001)
Volume 57, Issue 6, Pages (June 2000)
Distribution of postsynaptic density proteins in rat kidney: Relationship to neuronal nitric oxide synthase  Akihiro Tojo, David S. Bredt, Christopher.
Acute renal failure: From renal physiology to the renal transcriptome
Increased endothelin-1 expression in the kidney in hypercalcemic rats
Immunolocalization of phospholipase C isoforms in rat kidney
Insulin resistance and hypertension: new insights
Volume 76, Issue 1, Pages 6-7 (July 2009)
Endothelin antagonists in renal disease
Increased importin α protein expression in diabetic nephropathy
N. Maril, R. Margalit, S. Rosen, S.N. Heyman, H. Degani 
Volume 71, Issue 8, Pages (April 2007)
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Steven Ledbetter, Leslie Kurtzberg, Sineaid Doyle, Bruce M. Pratt 
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 78, Issue 3, Pages (August 2010)
Volume 70, Issue 1, Pages (July 2006)
Transplantation of developing metanephroi into adult rats
Presentation transcript:

Volume 74, Issue 1, Pages 91-100 (July 2008) Diabetes and radiocontrast media increase endothelin converting enzyme-1 in the kidney  M. Khamaisi, I. Raz, V. Shilo, A. Shina, C. Rosenberger, R. Dahan, Z. Abassi, R. Meidan, S. Lecht, S.N. Heyman  Kidney International  Volume 74, Issue 1, Pages 91-100 (July 2008) DOI: 10.1038/ki.2008.112 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Time-dependent changes in ECE-1 protein following the induction of diabetes. ECE-1 protein levels in kidney cortex (a), outer medulla (b), and inner medulla (c) as determined by western blot analysis. The right panels indicate the densitometric analysis for five animals in each group. CTR—control nondiabetic animals. D—diabetic. The duration of diabetes (days) is outlined on the x axis. Diabetes increased medullary ECE-1 protein expression over time. *P<0.01 compared with nondiabetic CTR animals. Kidney International 2008 74, 91-100DOI: (10.1038/ki.2008.112) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 The effect of contrast media on ECE-1 protein. ECE-1 protein levels in kidney cortex (a), outer medulla (b), and inner medulla (c) in nondiabetic control kidneys (CTR) and CTR infused with 8mlkg−1 of 60% meglumine iothalamate (CTR+CM). The right panels indicate the densitometric analysis for five animals in each group. CM increased ECE-1 protein expression selectively in the outer medulla. *P<0.01 compared with nondiabetic CTR animals. Kidney International 2008 74, 91-100DOI: (10.1038/ki.2008.112) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 The effect of diabetes and contrast media on renal ECE-1 protein. ECE-1 protein levels in kidney cortex (a), outer medulla (b), and inner medulla (c) in nondiabetic (CTR), 14 days diabetic (D), and 14 days diabetic animals infused with 8mlkg−1 of 60% meglumine iothalamate (D+CM). The right panels indicate the densitometric analysis for five animals in each group. Data are mean±s.e.m. Medullary ECE-1 protein increased in diabetic animals and were further augmented in the outer medulla and cortex following the administration of radiocontrast. *P<0.001 compared with nondiabetic CTR animals. **P<0.01 compared with nondiabetic CTR animals. Kidney International 2008 74, 91-100DOI: (10.1038/ki.2008.112) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 ECE-1 immunostaining in intact rat kidney. ECE-1 protein immunostaining in CTR kidneys, with representing sections at the cortex (a), outer stripe (b), and inner stripe of the outer medulla (c—longitudinal section; d—tangential section). Arrow=glomerular cell, most likely podocyte; asterisk=either unspecified distal tubule in the cortical labyrinth or thick ascending limb in the medulla; CD=collecting duct; PT=proximal tubule; and VB=vascular bundle. PTs are all negative (a and b), whereas strong perinuclear signals appear in most CDs of all renal zones (a–d). Additional signals appear in glomeruli (a), in distal tubules (a–d), and in interstitial and/or endothelial cells of the medulla (c and d), including VBs (d). Original magnification × 250. Kidney International 2008 74, 91-100DOI: (10.1038/ki.2008.112) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 ETB immunostaining: the effect of diabetes. ETB immunostaining of CTR (a) and 14-day STZ diabetic kidneys (b). These are horizontal cross-sections at the outermost level of the inner stripe of the outer medulla, illustrating vasa recta (vascular bundle, VB), surrounded by tubular components (medullary thick and thin limbs, and collecting ducts). Intense ETB immunostaining is noted in the diabetic kidney in vasa recta and peritubular vascular endothelial/interstitial cells. Original magnification × 400. Kidney International 2008 74, 91-100DOI: (10.1038/ki.2008.112) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 6 ET-1 and prepro-ET-1 expressions in culture endothelial cells. ET-1 released into the culture medium (a) and prepro-ET-1 mRNA in cultured endothelial cells (b). Cells were incubated for 24h with either 5.5 or 22.5mmoll−1 glucose, with or without concomitant exposure to meglumine iothalamate (9.7mg per 100ml iodine). Both ET-1 and prepro-ET-1 mRNA rose under hyperglycemic conditions and further increased with co-exposure to radiocontrast. Values represent the mean±s.d. of three experiments in triplicate. *P<0.04 compared with 5.5mmoll−1 glucose. **P<0.03 compared with 5.5mmoll−1 glucose, 22.5mmoll−1 glucose, and to 5.5mmoll−1 glucose+iothalamate. Kidney International 2008 74, 91-100DOI: (10.1038/ki.2008.112) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 7 ECE-1 protein and mRNA in cultured endothelial cells. ECE-1 protein densitometry (a), immunoblot (b), and mRNA (c) in cultured endothelial cells. Cells were incubated for 24h with either 5.5 or 22.5mmoll−1 glucose, with or without concomitant exposure to meglumine iothalamate (9.7mg per 100ml iodine). Both ECE-1 protein and mRNA rose under hyperglycemic conditions and further increased with co-exposure to radiocontrast. Values represent the mean±s.d. of 2 × 3 experiments in total. *P<0.01 compared with 5.5mmoll−1 glucose. **P<0.05 compared with 5.5mmoll−1 glucose, 22.5mmoll−1 glucose, and to 5.5mmoll−1 glucose+iothalamate. Kidney International 2008 74, 91-100DOI: (10.1038/ki.2008.112) Copyright © 2008 International Society of Nephrology Terms and Conditions